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The	pyrrolysine	 tRNA	synthetase-tRNA	pair	 is	 likely	one	of	 the	most	promiscuous	 tRNA-synthetase	
pairs	 found	 in	 nature,	 capable	 of	 genetically	 encoding	 a	 plethora	 of	 non-canonical	 amino	 acids	
through	 stop	 codon	 reassignment.	 Proteins	 containing	 reactive	 handles,	 post-translational	
modification	mimics	or	both	can	be	produced	in	practical	quantities,	allowing	inter	alia	the	probing	
of	biological	pathways,	the	generation	of	antibody-drug	conjugates,	and	enhancing	protein	function.	


























	The	usage	of	 this	amino	acid	 is	 largely	
confined	 to	 the	active	 site	of	methyltransferases,	wherein	 the	electrophilic	 imine	group	 is	used	 to	
capture	methylamine	and	mediate	the	transfer	of	CH3
+






Archaea	 to	 mono/di/trimethylamine-rich	 environments	 such	 as	 cattle	 rumen;
[8]
	 indeed,	 the	






Pyrrolysine	 is	encoded	by	 the	amber	 stop	codon,	TAG	 in	DNA	and	CUA	anticodon	on	 tRNA;	hence	
incorporation	 into	 proteins	 has	 necessitated	 overriding	 the	 stop	 function	 of	 this	 codon.	 This	 has	
occurred	 through	 the	 natural	 evolution	 of	 an	 orthogonal	 tRNA-tRNA	 synthetase	 (RS)	 pair	 in	
pyrrolysine-utilising	 organisms.	 Pyrrolysine	 is	 delivered	 to	 the	 ribosome	 during	 translation	 in	 the	
form	 of	 Pyl-tRNA
Pyl
,	 a	 complex	 formed	 through	 the	 charging	 of	 tRNA
Pyl
	 with	 pyrrolysine	 by	 PylRS,	
which	has	the	corresponding	CUA	anticodon.	PylRS	is	a	Class	II	tRNA	synthetase,	a	homodimer	in	the	









As	 is	 expected	 of	 a	 tRNA	 synthetase,	 specificity	 for	 the	 substrate	 amino	 acid	 versus	 other	 native	
amino	acids	is	very	high:	no	other	canonical	amino	acids	are	recognised	by	pylRS.	Attempts	to	hijack	
the	 amber	 stop	 codon	 for	 protein	 expression	 in	 E.	 coli	 cells	 using	 the	 tRNA
Pyl






concentrations	 of	 canonical	 amino	 acid,
[11]




highly	 promiscuous	 with	 unnatural	 amino	 acids.	 PylRS	 could	 be	 co-crystallised	 with	 not	 only	
pyrrolysine-AMP	 but	 also	 pyrrolysine	 analogue	 7	 and	 ATP	 (Scheme	 2).
[10]








	 such	 as	 the	Methanocaldococcus	 janaschii	pair	 capable	 of	 introducing	 various	 tyrosine	
analogues	 into	 proteins.
[14]






The	 limits	 on	 the	 design	 of	 pyrrolysine	 analogues	 chiefly	 arise	 from	 the	 specificity	 of	 PylRS:	 any	
analogue	 must	 have	 some	 affinity	 for	 the	 hydrophobic	 binding	 pocket.	 Key	 interactions	 involve	
Tyr384,	Asn346,	Trp417,	Cys348	and	Val401	inter	alia	in	PylRS	from	M.	mazei	(Figure	2).	The	former	




	Given	 this	 reasoning,	most	pyrrolysine	analogues	 involve	a	different	amide	
(or	 carbamate)	 on	 the	 ε-amino	 group,	 with	 an	 additional	 hydrogen	 bond	 acceptor	 replacing	 the	
imine	 and	 a	 moderate-size	 hydrophobic	 group	 replacing	 the	 pyrroline	 ring.	 This	 is	 illustrated	 by	
analogues	7-9,	with	a	 common	set	of	analogues	being	dipeptides	 such	as	9.	Notably,	 the	α-amino	



















	 and	 AzZ-Lys	 13
[18]
	 with	 traditional	 “protecting	 groups”	 or	 variants	 thereof	
required	 mutations	 to	 the	 active	 site	 (Scheme	 3).	 Incorporating	 the	 small	 derivative	 5	 required	









transforming	 genes	 for	 pylRS	 and	 tRNA
Pyl








use	 of	 evolved	 pyrrolysine	 tRNAs	 for	 further	 improved	 yields,	 even	with	multiple	 reassigned	 stop	
codons.
[22]
	 A	 common	 problem	 experienced	 is	 protein	 truncation	 arising	 from	 translation	
termination	at	 the	 reassigned	codon,	 lowering	protein	yields;	 this	has	been	circumvented	 through	
the	 use	 of	 release	 factor	 one	 (RF1)	 knockout	 strains,
[23]














of	 a	 suitable	 PylRS	 permitted	 incorporation	 of	 acetylated	 lysine	 5	 into	 green	 fluorescent	 protein	
(GFP),	 myoglobin
[19]
	 and	 chloramphenicol	 acetyltransferase,
[25]




	 allowing	 a	 full	 evaluation	 of	 acetylation	 in	 various	 processes	 such	 as	 chromatin	
remodelling	 and	 DNA	 breathing	 using	 both	 variants.	 Notably,	 this	 residue	 has	 been	 resistant	 to	
modification	 through	 other	 methods.	 Differentially	 acetylated	 variants	 of	 H2A	 and	 H2B	 subunits	
were	 also	 prepared.	 Optimisation	 of	 this	 method	 later	 allowed	 production	 of	 full-length	 H3	
containing	 four	acetylated	 lysine	 residues	 in	E.	coli	 cells,
[27]
	 and	 further	work	allowed	concomitant	










surrogate	14	 should	be	compatible	with	an	analogous	strategy	 to	yield	methylated	 lysine	 (Scheme	
4).	 Indeed,	 incorporation	 and	 post-translational	 deprotection	 yielded	 modified	 myoglobin	 and	
histone	 H3K9me1,
[29]
	 with	 K9	 methylation	 hence	 shown	 to	 be	 essential	 for	 the	 binding	 of	 H3	 to	
heterochromatin	 protein	 1.	 Further	 work	 demonstrated	 how	 this	 route	 could	 be	 used	 to	 install	










	 The	 cleavage	 conditions	 for	 Alloc	 are	 evidently	 preferable	 as	 the	 biologically	







The	 installation	 of	 dimethylated	 lysine	 4	 in	 proteins	 has	 been	 a	 far	 more	 elusive	 goal.	 Efforts	 to	
evolve	a	pylRS	recognising	4	 failed,	and	deprotection	strategies	are	not	possible	due	to	the	limited	








modified	 strategy	was	designed	 to	 install	4	 in	 a	more	 facile	manner.	 The	UAA	16,	 an	unsaturated	
derivative	of	13,	was	 incorporated	 into	GFP	with	an	engineered	M.	mazei	PylRS	and	the	azido-Cbz	





















In	 addition	 to	methylation	 and	 acetylation,	 histone	 lysine	 residues	 have	 been	 found	modified	 by	
other	 carbonyl	 groups,	 and	 further	 work	 has	 naturally	 involved	 using	 stop	 codon	 suppression	 to	













to	 novel	 analogue	 22	 and	 protected	 Piv-Lys	 23,	 with	 directed	 evolution	 of	 PylRS	 again	 proving	
essential.	 A	 creative	 strategy	 to	 incorporate	 acylated	 lysine	 derivatives	 made	 use	 of	
azidohomoleucine	 24	 in	 combination	 with	 on-protein	 traceless	 Staudinger	 ligations	 to	 afford	
acetylated	 and	 photocaged	 succinylated	 lysine	 residues,	 with	 the	 key	 property	 of	 being	 able	 to	














protected	 derivatives	 of	 methyllysine	 3	 could	 also	 be	 incorporated	 using	 the	 N-methylated	
derivatives	 of	 12	 and	 25	 which	 are	 unmasked	 by	 palladium
[40]




the	use	of	UV	 radiation	 is	not	desirable	 in	 live	cell	work.	Palladium	deprotection	was	 further	used	
with	Alloc-Lys	15	and	Proc-Lys	26	to	demonstrate	site-specific	caging	of	individual	lysine	residues	in	








biocompatibility	 and	 stability	of	 coupling	partners	 and	 fast	 kinetics	have	 facilitated	 its	widespread	
adoption	 in	 chemical	 biology.	 Use	 for	 protein	modification	was	 initially	 documented	 using	 a	 viral	
coat	 protein	 non-selectively	 labelled	 with	 an	 azido-acyl	 linker	 which	 subsequently	 underwent	
ligation	with	 alkynyl	 fluorescein	 and	 an	 alkyne-containing	 dansyl-BSA	 conjugate.
[43]
	 This	 first	 foray	
into	 copper-catalysed	 click	 chemistry	 (CuAAC)	 in	 protein	 modification	 was	 an	 unequivocal	
demonstration	of	the	potential	of	the	technique,	albeit	suffering	from	the	drawback	of	a	lack	of	site	
specificity.	 Stop	 codon	 suppression	 is	 a	 near-perfect	 solution	 to	 this	 problem,	 with	 the	 highly	
modifiable	nature	of	both	techniques	being	pleasingly	synergistic.	Azides	and	alkynes	13	and	27-31	
(Scheme	 7)	 have	 been	 encoded	 using	 pyrrolysine	 analogues	 and	 used	 in	 CuAAC	 to	 create	















including	 SPAAC-induced	 amine	 group	 unmasking,
[49]









of	 faster	 kinetics	 than	 CuAAC	 and	 SPAAC
[52]
	 whilst	 also	 retaining	 fluorogenicity.	 An	 assortment	 of	




	 rapid	 labelling	 of	 proteins	 in	 vivo,
[54]
	 live	 cell	 labelling,
[55]





	 and	 SPIEDAC-initiated	 rapid	 decaging	 via	 a	 novel	
rearrangement	 mechanism.
[58]
	 Stop	 codon	 suppression	 and	 bioorthogonal	 chemistry	 are	 highly	











and	 p-iodo-Phe	 37	 (Scheme	 8).	Whilst	 36	 required	 only	 N346	 and	 C348	mutations	 for	 successful	
incorporation,	the	most	successful	PylRS	with	37	required	mutations	to	five	of	the	six	selected	active	
site	 residues.	GFP	containing	36	and	37	could	be	produced,	and	brominated	analogue	38	was	also	
shown	 to	 be	 a	 substrate	 for	 the	37-recognising	 PylRS.
[59]
	 The	 synthetic	 utility	 of	 this	method	was	












Trifluoromethylated	 UAA	 48	 found	 instant	 use	 as	 a	 sensitive	
19
F	 handle,	 allowing	 monitoring	 of	
protein	 folding	 states	 through	 NMR	 alongside	 other	 fluorinated	 unnatural	 amino	 acids.
[62]
	 A	 key	





which	 can	 undergo	 key	 bioorthogonal	 reactions	 such	 as	 oxime	 ligation.	 Other	 methods	 to	 install	




	 This	 finding	 circumvented	 a	 requirement	 to	 utilise	 the	 pyrrolysine	
biosynthetic	pathway	to	install	aldehydes	in	proteins,	with	previous	work	making	use	of	the	imine	in	












incorporated	 in	 competition	 with	 the	 desired	 Phe	 analogue.	 It	 is	 worth	 noting	 that	 other	 Phe	
10	
	










Whilst	 other	 tRNA/RS	 pairs	 have	 permitted	 the	 genetic	 encoding	 of	 protected	 cysteine	
derivatives,
[68]
	 the	ability	 to	 incorporate	derivatives	of	unprotected	 cysteine	62	 using	genetic	 code	
expansion	has	also	been	a	highly	sought-after	goal,	given	the	broad	range	of	reactions	in	which	the	
thiol	 group	 can	 participate.	 Protected	 lysine	 thiol	 63	 (Scheme	 9)	 was	 shown	 to	 be	 a	 suitable	




the	 unprotected	 Cys-Lys	 dipeptides	64S	 and	64R,	 again	 allowing	 ubiquitination	 using	 NCL.
[70]
	64S,	
with	 stereochemical	 configuration	 matching	 that	 of	 pyrrolysine,	 was	 also	 shown	 to	 be	 a	 better	
substrate	for	this	PylRS	variant	than	diastereomer	64R.	Further	work	demonstrated	the	importance	
of	configuration	and	PylRS	variant	as	the	wild	type	M.	mazei	PylRS	could	recognise	64S	but	not	64R,	




reactive	 amino	 acid	 65a,	 a	 4-thiazolidine	 derivative	 of	 64R	 (to	 circumvent	 pyruvate	 adduct	





barkeri	 pylRS	 as	 a	 racemate,	 was	 also	 found	 to	 be	 a	 useful	 cage	 for	 reactivity.	 Silver-mediated	




could	 be	 installed	 using	 a	 mutant	M.	 barkeri	 PylRS	 without	 the	 need	 for	 a	 lysine	 backbone,
[74]
	


























substrate	 kinase	 Pak1,	 demonstrating	 the	 phosphorylation	 cascade	 occurring	 between	 these	 two	







motif	 of	 HIV-1	 trans-activator	 of	 transcription	 (TAT)	 protein,	 the	motif	 responsible	 for	 binding	 to	
trans-activation	 response	 RNA	 (TAR),	 and	 upon	 irradiation	 with	 red	 light	 in	 the	 presence	 of	
methylene	blue	and	oxygen	the	covalent	TAT-TAR	complex	was	formed	in	vitro.		
Another	 field	making	 intelligent	use	of	 amber	 stop	 codon	 suppression	 is	 enzyme	engineering.	 The	
activity	of	 an	enzyme	 is	naturally	dependent	on	active	 site	 residues,	 and	hence	mutations	 in	 such	
residues	 can	 impede	 or	 improve	 enzyme	 performance.	 Stop	 codon	 suppression	 allows	 such	
mutations	 to	 include	 non-canonical	 amino	 acids	 to	 further	 allow	 e.g.	 fine-tuning	 of	 hydrogen	
bonding,	 the	 pKa	 values	 of	 residues	 or	 metal	 chelation	 beyond	 that	 of	 the	 canon.	 Methylated	
histidine	(His)	71,	along	with	other	His	analogues	72-75,	have	been	found	to	be	taken	up	by	a	PylRS	
mutant	 engineered	 to	 contain	 an	 amino	 acid	 binding	 site	 much	 smaller	 than	 the	 wild	 type,	 and	


















In	 tandem	 with	 bioorthogonal	 reactions	 such	 as	 SPAAC,	 SPIEDAC	 and	 palladium-catalysed	 cross-














only	 sequence	 constraint	 is	 the	 stop	 codon	 requirement,	whilst	 other	 enzymatic	methods	 such	 as	
FGE-catalysed	elimination	frequently	require	recognition	sequences.	Previous	chemical	methods	to	
install	 azides	 by	 protein	 acylation	 have	 been	 made	 entirely	 redundant	 due	 to	 the	 lack	 of	 site	
specificity	 compared	 to	 that	 inherent	 in	 the	 pyrrolysine	 amber	 stop	 codon	 suppression	 system.	






















































































































































































The pyrrolysine tRNA synthetase-
tRNA pair is capable of genetically 
encoding a plethora of non-canonical 
amino acids through amber stop 
codon suppression. This Minireview 
summarises the development of 
pyrrolysine amber stop codon 
suppression, presents some of the 
considerations required to utilise this 
technique to its greatest potential, and 
showcases the creative ways in which 
this technique has led to a better 
understanding of biological systems. 
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